MASH PIs - Velocity (1)
Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions
October 25, 2023 07:04 ET | Velocity Clinical Research, Inc.
• Add two KOLs: Dr Kris Kowdley and Dr Nadege Gunn • Builds on existing MASH/MASLD capabilities at 23 sites globally DURHAM N.C., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical...
New Principal Investigators at Velocity Clinical Research. From left to right: Shilpa Muthusamy, MD, Matt Fisher, MD
Velocity opens three U.K. greenfield clinical research sites
October 04, 2023 04:36 ET | Velocity Clinical Research, Inc.
LONDON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, announced it is opening greenfield clinical research sites in...
Dr. Paul Evans, Chief Executive and President of Velocity
Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites
July 11, 2023 07:09 ET | Velocity Clinical Research, Inc.
Partnership builds on Velocity’s embedded site model strategy and expands access to clinical trials for Privia Health patients and providersFirst site will open in Abilene, TX DURHAM, N.C., July 11,...
Dr. Paul Evans, Chief Executive and President of Velocity
Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business
December 15, 2022 06:00 ET | Velocity Clinical Research, Inc.
DURHAM, N.C., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading integrated research site organization, today announces its acquisition of Meridian Clinical...
Velocity_Press-Release-Image_121122_News-site_Long2
Velocity Clinical Research expands to UK
November 17, 2022 02:00 ET | Velocity Clinical Research, Inc.
LONDON, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading integrated research site organisation, today announces its expansion into the U.K. with the acquisition...
Velocity_Patient-Report-2022_Press-release_v1
Velocity Clinical Research reveals findings from US patient survey on decentralization in clinical research
September 28, 2022 07:30 ET | Velocity Clinical Research, Inc.
Patient-facing technology use is not as widespread as expected, although patients are very open to its useAn overwhelming majority of do not want home visitsYoung adults (ages 18-34) are taking part...
Dr. Paul Evans, Chief Executive and President of Velocity
Velocity Clinical Research growth skyrockets with eight site acquisitions
September 07, 2022 07:06 ET | Velocity Clinical Research, Inc.
DURHAM, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading integrated research site organization, today announces it has acquired MedPharmics, a multi-site...